Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06206096
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-01-04
Brief Title:
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Organization Data
Organization:
Chinese PLA General Hospital
Class:
OTHER
Study ID:
ZLNK-CRC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chinese PLA General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Dai Guanghai
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Chinese PLA General Hospital
Old Name:
None
Old Organization:
None